Premanifest Huntington's Disease Extension Study II: Creatine Safety & Tolerability

Clinical trial NCT01411163 · COMPLETED

Trial details

NCT number: NCT01411163
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Huntington's Disease

Start date: 2010-04-01
Primary completion: 2013-05-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.